Works matching DE "JANUS kinases"

Results: 1914

Association of Language Preference with Therapeutic Care for Hospitalized COVID-19 Patients.

Published in:

Journal of Racial & Ethnic Health Disparities, 2025, v. 12, n. 4, p. 2454, doi. 10.1007/s40615-024-02065-2

By:

Quadri, Nasreen S.;
Martins, Summer L.;
Sidebottom, Abbey;
Mohamed, Samira;
Ha, Ngoc;
Nguyen, Duc;
Patel, Love;
Kethireddy, Rajesh

Publication type:

Article

JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 525, doi. 10.1007/s40257-025-00946-8

By:

Iorizzo, Matilde;
Sechi, Andrea;
Neubauer, Zachary J. K.;
Zhou, Maggie;
Lipner, Shari R.

Publication type:

Article

Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 611, doi. 10.1007/s40257-025-00932-0

By:

King, Brett;
Mostaghimi, Arash;
Shimomura, Yutaka;
Piraccini, Bianca Maria;
Blume-Peytavi, Ulrike;
Sontag, Angelina;
Dutronc, Yves;
Denning, Karen;
Kolodsick, Jill;
Lu, Xiaoyu;
Srivastava, Ayush;
Sinclair, Rodney

Publication type:

Article

ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.

Published in:

Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03309-3

By:

Dosanjh, Davinder Paul Singh;
Darrah, Erika;
Jensen, Tina Jellesmark;
Jevnikar, Zala;
Halvorson, Alese;
Cardner, Mathias;
Hughes, Rod;
Grant, Sarah S.;
Platt, Adam;
Brightling, Chris E.

Publication type:

Article

Recent Advances in Management of Vitiligo.

Published in:

Indian Journal of Dermatology, 2025, v. 70, n. 4, p. 201, doi. 10.4103/ijd.ijd_158_25

By:

Das, Kinnor;
Sarkar, Rashmi;
Sinha, Surabhi

Publication type:

Article

The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases.

Published in:

Acta Marisiensis. Seria Medica, 2025, v. 71, n. 2, p. 95, doi. 10.2478/amma-2025-0018

By:

Sharma, Anurag;
Khan, Zoya;
Nath, Rajendra;
Dixit, Rakesh Kumar

Publication type:

Article

JAK-STAT Signaling in Autoimmunity and Cancer.

Published in:

ImmunoTargets & Therapy, 2025, v. 15, p. 523, doi. 10.2147/ITT.S485670

By:

Parveen, Sana;
Fatma, Mariyam;
Mir, Snober Shabnam;
Dermime, Said;
Uddin, Shahab

Publication type:

Article

Multisystemic Consequences Following Oclacitinib Maleate (Apoquel<sup>®</sup>) Overdose Ingestion in Cats and Dogs.

Published in:

Journal of Medical Toxicology, 2025, v. 21, n. 3, p. 360, doi. 10.1007/s13181-025-01076-7

By:

Swanson, Leah D.;
Hommerding, Holly A.;
Schmid, Renee D.;
Hovda, Lynn R.

Publication type:

Article

SARS-CoV-2 ORF7a Protein Impedes Type I Interferon-Activated JAK/STAT Signaling by Interacting with HNRNPA2B1.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 12, p. 5536, doi. 10.3390/ijms26125536

By:

Wen, Yujie;
Li, Chaochao;
Tang, Tian;
Luo, Chao;
Lu, Shan;
Lyu, Na;
Li, Yongxi;
Wang, Rong

Publication type:

Article

Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 11, p. 2563, doi. 10.1111/jog.15761

By:

Yunianto, Irfan;
Currie, Margaret;
Chitcholtan, Kenny;
Sykes, Peter

Publication type:

Article

Human Wharton's jelly‐derived mesenchymal stem cells prevent pregnancy loss in a rat by JAK/STAT‐mediated immunomodulation.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 10, p. 2417, doi. 10.1111/jog.15748

By:

Ding, Xiaoying;
Wu, Rongrong;
Jin, Beibei;
Zhu, Chunyu;
Zhang, Yuquan;
Yang, Xiaoqing

Publication type:

Article

Screening of genes related to survival prognosis of cervical squamous cell carcinoma and construction of prognosis prediction model.

Published in:

Journal of Obstetrics & Gynaecology Research, 2021, v. 47, n. 9, p. 3310, doi. 10.1111/jog.14827

By:

Qin, Rui;
Cao, Lu;
Ye, Cong;
Wang, Junrong;
Sun, Ziqian

Publication type:

Article

Zeylenone inhibits proliferation and promotes apoptosis in ovarian carcinoma cells via Janus kinase 2 / signal transducers and activators of transcription 3 pathways.

Published in:

Journal of Obstetrics & Gynaecology Research, 2018, v. 44, n. 8, p. 1451, doi. 10.1111/jog.13690

By:

Xu, Xiaoli;
Shi, Junyu;
Gao, Hongyan;
Li, Qin

Publication type:

Article

Interleukin‐6 regulates expression of Fos and Jun genes to affect the development of mouse preimplantation embryos.

Published in:

Journal of Obstetrics & Gynaecology Research, 2018, v. 44, n. 2, p. 253, doi. 10.1111/jog.13498

By:

Yu, Chunhua;
Zhang, Xinyan;
Wang, Li;
Liu, Yinan;
Li, Na;
Li, Min;
Chen, Li;
Liu, Yingyu;
Yao, Yuanqing

Publication type:

Article

Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 10, p. 2823, doi. 10.1007/s10067-023-06660-2

By:

Junfei, Zhou;
Meihua, Gao;
Shuai, Zhang;
Xiangting, Lu;
Zhidan, Lei;
Tianming, Cheng;
Yajing, Liu;
Chu, Tianshu;
Lipu, Shi

Publication type:

Article

Refractory alopecia in lupus treated with tofacitinib — a case-based review.

Published in:

2023

By:

Sarkar, Rajdeep;
MV, Prakashini;
Hinduja, Naga;
Sethy, Mitanjali;
Kar, Hemanta;
Ahmed, Sakir

Publication type:

Case Study

Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease.

Published in:

Clinical Rheumatology, 2020, v. 39, n. 12, p. 3543, doi. 10.1007/s10067-020-05136-x

By:

Ben Nessib, Dorra;
Ferjani, Hanene;
Maatallah, Kaouther;
Rahmouni, Safa;
Kaffel, Dhia;
Hamdi, Wafa

Publication type:

Article

Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.

Published in:

Clinical Rheumatology, 2018, v. 37, n. 10, p. 2611, doi. 10.1007/s10067-018-4199-7

By:

Kunwar, Sumit;
Collins, Christopher E.;
Constantinescu, Florina

Publication type:

Article

Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study.

Published in:

Clinical Rheumatology, 2018, v. 37, n. 9, p. 2381, doi. 10.1007/s10067-018-4221-0

By:

van der Heijde, Désirée;
Durez, Patrick;
Schett, Georg;
Naredo, Esperanza;
Østergaard, Mikkel;
Meszaros, Gabriella;
De Leonardis, Francesco;
de la Torre, Inmaculada;
López-Romero, Pedro;
Schlichting, Douglas;
Nantz, Eric;
Fleischmann, Roy

Publication type:

Article

Insights into diet-associated oxidative pathomechanisms in inflammatory bowel disease and protective effects of functional amino acids.

Published in:

Nutrition Reviews, 2023, v. 81, n. 1, p. 95, doi. 10.1093/nutrit/nuac039

By:

Ji, Yun;
Yang, Ying;
Sun, Shiqiang;
Dai, Zhaolai;
Ren, Fazheng;
Wu, Zhenlong

Publication type:

Article

Interleukin-6: A Masterplayer in the Cytokine Network.

Published in:

Oncology, 2020, v. 98, n. 3, p. 131, doi. 10.1159/000505099

By:

Uciechowski, Peter;
Dempke, Wolfram C.M.

Publication type:

Article

Upadacitinib is associated with clinical response and steroid-free remission for children and adolescents with inflammatory bowel disease.

Published in:

Journal of Pediatric Gastroenterology & Nutrition, 2025, v. 80, n. 1, p. 133, doi. 10.1002/jpn3.12408

By:

Runde, Joseph;
Ryan, Kelsey;
Hirst, Joseph;
Lebowitz, Jonathan;
Chen, Wenya;
Brown, Jeffrey;
Strople, Jennifer

Publication type:

Article

OP020 INHIBITION OF JAK 1/2 AS A POTENTIAL TARGET IN THE TREATMENT OF RECALCITRANT PYODERMA GANGRENOSUM: A CASE REPORT.

Published in:

Journal of Wound Management, 2023, v. 24, n. 2, p. 392

By:

Margiotta, Flavia Manzo;
Michelucci, Alessandra;
Granieri, Giammarco;
Salvia, Giorgia;
Janowska, Agata;
Romanelli, Marco

Publication type:

Article

The Investigation Frequency of JAK2 Gene Mutation in Glomerulonephritis.

Published in:

Journal of Tepecik Education & Research Hospital / İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 2023, v. 33, n. 1, p. 45, doi. 10.4274/terh.galenos.2021.55899

By:

Yıldırım, Tuba Demirci;
Soyaltın, Utku Erdem;
Koç, Altuğ;
Yıldız, Serkan;
Tanrısev, Mehmet;
Kutbay, Yaşar Bekir;
Ekinci, Ferhat;
Yıldırım, Süleyman;
Akar, Harun;
Ceylan, Cengiz

Publication type:

Article

Evaluation of JAK/STAT Signaling Pathway-associated Protein Expression at Implantation Period: An Immunohistochemical Study in Rats.

Published in:

Journal of Tepecik Education & Research Hospital / İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 2022, v. 32, n. 1, p. 131, doi. 10.4274/terh.galenos.2021.22599

By:

Köse, Can;
Vatansever, Seda;
İnan, Sevinç;
Kırmaz, Cengiz;
Gürel, Çevik;
Erışık, Derya;
Kuşçu, Gökçe Ceren;
Özbilgin, Kemal

Publication type:

Article

Alopecia areata - základní charakteristika onemocnění a přehled současných a nových možností terapie.

Published in:

Dermatologie Pro Praxi, 2022, v. 16, n. 1, p. 9, doi. 10.36290/der.2022.001

By:

Štěpánková, Eva;
Boháčová, Pavla;
Arenbergerová, Monika

Publication type:

Article

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Published in:

JAMA Network Open, 2021, v. 4, n. 1, p. e2034750, doi. 10.1001/jamanetworkopen.2020.34750

By:

Wu, Hengwei;
Shi, Jimin;
Luo, Yi;
Tan, Yamin;
Zhang, Mingming;
Lai, Xiaoyu;
Yu, Jian;
Liu, Lizhen;
Fu, Huarui;
Huang, He;
Zhao, Yanmin

Publication type:

Article

A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years.

Published in:

Modern Rheumatology, 2021, v. 31, n. 3, p. 543, doi. 10.1080/14397595.2020.1836789

By:

Tsutomu Takeuchi;
Yoshiya Tanaka;
Mitsuhiro Rokuda;
Hiroyuki Izutsu;
Yuichiro Kaneko;
Musashi Fukuda;
Daisuke Kato

Publication type:

Article

Efficacy and safety of peficitinib in rheumatoid arthritis.

Published in:

Modern Rheumatology, 2020, v. 30, n. 5, p. 773, doi. 10.1080/14397595.2020.1794103

By:

Yuko Kaneko

Publication type:

Article

A review of upadacitinib in rheumatoid arthritis.

Published in:

Modern Rheumatology, 2020, v. 30, n. 5, p. 779, doi. 10.1080/14397595.2020.1782049

By:

Yoshiya Tanaka

Publication type:

Article

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.

Published in:

Modern Rheumatology, 2020, v. 30, n. 1, p. 36, doi. 10.1080/14397595.2019.1583711

By:

Masayoshi Harigai;
Tsutomu Takeuchi;
Smolen, Josef S.;
Winthrop, Kevin L.;
Atsushi Nishikawa;
Rooney, Terence P.;
Saifan, Chadi G.;
Maher Issa;
Yoshitaka Isaka;
Naotsugu Akashi;
Taeko Ishii;
Yoshiya Tanaka

Publication type:

Article

Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.

Published in:

Modern Rheumatology, 2019, v. 29, n. 6, p. 928, doi. 10.1080/14397595.2018.1537556

By:

Masakazu Kondo;
Hisakata Yamada

Publication type:

Article

Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data.

Published in:

Modern Rheumatology, 2019, v. 29, n. 5, p. 756, doi. 10.1080/14397595.2018.1553489

By:

Tsutomu Takeuchi;
Hisashi Yamanaka;
Kunihiro Yamaoka;
Shoko Arai;
Shigeyuki Toyoizumi;
DeMasi, Ryan;
Yuri Fukuma;
Tomohiro Hirose;
Naonobu Sugiyama;
Zwillich, Samuel H.;
Yoshiya Tanaka

Publication type:

Article

Response to Dr Minota's Letter to the Editor of Modern Rheumatology Regarding a Study of Tofacitinib in Japanese Patients with Rheumatoid Arthritis.

Published in:

Modern Rheumatology, 2016, v. 26, n. 2, p. 318, doi. 10.3109/14397595.2015.1012799

By:

Yoshiya Tanaka;
Zwillich, Samuel H.

Publication type:

Article

Importancia de la ruta de señalización JAK/STAT en la sepsis.

Published in:

Acta Médica Peruana, 2022, v. 39, n. 2, p. 151, doi. 10.35663/amp.2022.392.2240

By:

Alfonso Torres-Carpio, Daniel;
Santiago Lanas-Mendoza, Enrique;
Enrique Rueda-Barragán, Fernando;
Vélez Páez, Pablo Andrés;
Torres Cabezas, Pedro René;
Jara González, Fernando Esteban;
Montalvo Villagómez, Mario Patricio;
Aguayo Moscoso, Santiago Xavier;
Luis Vélez-Páez, Jorge

Publication type:

Article

Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7186, doi. 10.3390/jcm13237186

By:

Neri, Benedetto;
Mancone, Roberto;
Fiorillo, Mariasofia;
Schiavone, Sara Concetta;
Migliozzi, Stefano;
Biancone, Livia

Publication type:

Article

Role of Janus Kinase Inhibitors in Therapy of Psoriasis.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4307, doi. 10.3390/jcm10194307

By:

Słuczanowska-Głąbowska, Sylwia;
Ziegler-Krawczyk, Anna;
Szumilas, Kamila;
Pawlik, Andrzej

Publication type:

Article

The intervention of Jianpifuwei granule on mucosal injury of precancerous lesion of gastric cancer via the IL-6/JAK/STAT3 axis and its mechanisms.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 4, p. 392, doi. 10.3872/j.issn.1007-385x.2025.04.007

By:

KANG Juying;
GUAN Huiying;
LI Peirun;
ZHANG Liming;
DUAN Yongqiang

Publication type:

Article

KHSRP靶向调控JAK1/STAT3 信号通路对食管胃结合部腺癌恶性生物学行为的影响.

Published in:

Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 1, p. 38, doi. 10.3872/j.issn.1007-385x.2025.01.006

By:

张海峰;
王梦瑶;
王晓龙;
刘洋洋;
李丽;
韦海涛

Publication type:

Article

基于EGFR/AKT和JAK2/STAT3 通路研究α-常春藤皂苷单独或与顺铂联用对非小细胞肺癌细胞增殖与凋亡的影响

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 4, p. 333, doi. 10.3872/j.issn.1007-385x.2024.04.003

By:

朱志明;
王苏美;
唐青;
王晰;
万信良;
莫瀚丹;
贾璐瑜;
俞晓燕;
周绮纯

Publication type:

Article

溶瘤新城疫病毒抑制IL-6 诱导的人胶质母细胞瘤U87MG细胞的迁移和侵袭.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 1, p. 27, doi. 10.3872/j.issn.1007-385x.2024.01.004

By:

陶薇伊;
秦莹;
吴醒;
郑婷婷;
樊晓晖;
梁莹

Publication type:

Article

STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases.

Published in:

International Reviews of Immunology, 2024, v. 43, n. 6, p. 394, doi. 10.1080/08830185.2024.2395274

By:

Tolomeo, Manlio;
Cascio, Antonio

Publication type:

Article

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

Published in:

Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338

By:

Piha-Paul, Sarina A;
Xu, Binghe;
Dumbrava, Ecaterina E;
Fu, Siqing;
Karp, Daniel D;
Meric-Bernstam, Funda;
Hong, David S;
Rodon, Jordi A;
Tsimberidou, Apostolia M;
Raghav, Kanwal;
Ajani, Jaffer A;
Conley, Anthony P;
Mott, Frank;
Fan, Ying;
Fan, Jean;
Peng, Peng;
Wang, Hui;
Ni, Shumao;
Sun, Caixia;
Qiang, Xiaoyan

Publication type:

Article

Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease.

Published in:

Oncologist, 2022, v. 27, n. 8, p. 685, doi. 10.1093/oncolo/oyac076

By:

Martini, Dylan J;
Chen, Yi-Bin;
DeFilipp, Zachariah

Publication type:

Article

PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.

Published in:

Oncologist, 2022, v. 27, n. 8, p. e661, doi. 10.1093/oncolo/oyac072

By:

Kaplan, Henry G;
Jin, Ruyun;
Bifulco, Carlo B;
Scanlan, James M;
Corwin, David R

Publication type:

Article

FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 493, doi. 10.1093/oncolo/oyac042

By:

Le, Robert Q;
Wang, Xin;
Zhang, Hongfei;
Li, Hongshan;
Przepiorka, Donna;
Vallejo, Jonathon;
Leong, Ruby;
Ma, Lian;
Goldberg, Kirsten B;
Pazdur, Richard;
Theoret, Marc R;
Claro, Angelo De

Publication type:

Article

Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients.

Published in:

Oncologist, 2021, v. 26, n. 11, p. e2082, doi. 10.1002/onco.13903

By:

Anandappa, Annabelle J.;
Hobbs, Gabriela S.;
Dey, Bimalangshu R.;
El‐Jawahri, Areej;
Frigault, Matthew J.;
McAfee, Steven L.;
O'Donnell, Paul V.;
Spitzer, Thomas R.;
Chen, Yi‐Bin;
DeFilipp, Zachariah

Publication type:

Article

Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.

Published in:

Oncologist, 2021, v. 26, n. 5, p. 406, doi. 10.1002/onco.13769

By:

Tremblay, Douglas;
Rippel, Noa;
Feld, Jonathan;
El Jamal, Siraj M.;
Mascarenhas, John

Publication type:

Article

Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?

Published in:

Oncologist, 2016, v. 21, n. 4, p. 475, doi. 10.1634/theoncologist.2015-0380

By:

Nazha, Aziz;
Gerds, Aaron T.

Publication type:

Article

Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation.

Published in:

Journal of Pediatric Research, 2022, v. 9, n. 2, p. 197, doi. 10.4274/jpr.galenos.2022.69335

By:

Eker, Nurşah;
Taş, Burcu Tufan;
Doğru, Ömer;
Şenay, Emel;
Tokuç, Ayşe Gülnur;
Koç, Ahmet

Publication type:

Article